Evidence map›Paper›PMID 8035808›Full record

ArticleMolecular and cellular biology1994

Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

I C Oliveira, N Mukaida, K Matsushima, J Vilcek

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells.American journal of respiratory cell and molecular biology · 2008
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. IFNalpha/beta promotes cell survival by activating NF-kappa B.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

I C OliveiraDepartment of Microbiology, New York University Medical Center, New York 10016.
N Mukaida
K Matsushima
J Vilcek

Funding

MECHANISMS OF TNF/CYTOKINE ACTIONSR35CA049731 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI VILCEK, JAN T · 1991 to 1997
–
NCI NIH HHS NCI R35CA49731
6 · The paper itself

Abstract

The cytokine interleukin-8 (IL-8) is an important mediator of neutrophil, lymphocyte, and basophil chemotaxis and activation. Earlier we demonstrated that beta interferon (IFN-beta) can inhibit tumor necrosis factor (TNF)-induced IL-8 gene expression at the transcriptional level, apparently by a novel mechanism. To define the cis-acting elements and trans-acting factors involved in this inhibition, DNA constructs containing portions of the 5'-flanking region of the IL-8 gene were linked to the chloramphenicol acetyltransferase (CAT) reporter gene and transfected into human diploid FS-4 fibroblasts. The region spanning positions -98 to +44 was sufficient to confer both inducibility by TNF and inhibition by simultaneous treatment with IFN-beta. Inhibition of TNF- or IL-1-induced CAT activity by IFN-beta or IFN-alpha was also observed when a DNA fragment containing only the NF-IL-6 and NF-kappa B sites (positions -94 to -70) was placed upstream of the homologous or a heterologous minimal promoter. A construct containing three copies of the NF-kappa B element in front of the CAT gene also was inducible by TNF, and this stimulatory effect too was inhibited by IFN-beta, indicating that the NF-kappa B element is sufficient to confer inhibition by IFN-beta. This inhibitory effect was specific for the NF-kappa B site of the IL-8 gene since it was less marked with constructs containing three copies of the NF-kappa B site from the HLA-B7 gene. Gel shift assays with a probe containing the NF-kappa B and NF-IL-6 binding sites of the IL-8 gene (positions -101 to -63) showed that IFN-beta treatment did not block the activation of NF-kappa B proteins or their ability to bind to the NF-kappa B site. However, nuclear extracts from cells treated with TNF in the presence of IFN-beta gave rise to an additional band that appears to contain protein components from the NF-kappa B and NF-IL-6 families. NF-kappa B site-mediated suppression of IL-8 gene expression by IFN-beta represents a hitherto unknown mechanism and target of IFN action.

Indexed as

Gene Expression RegulationBase SequenceCell LineDNA-Binding ProteinsDNA PrimersHumansInterferon-alphaInterferon alpha-2Interferon-betaInterferon-gammaInterleukin-1Interleukin-8Macromolecular SubstancesMolecular Sequence DataNF-kappa BNuclear ProteinsDNA-Binding ProteinsDNA PrimersInterferon-alphaInterferon alpha-2Interferon-betaInterferon-gammaInterleukin-1Interleukin-8Macromolecular SubstancesNF-kappa BNuclear ProteinsRecombinant ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID8035808
PMCPMC359049
OpenAlexW2164925666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.